Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy

BACKGROUND: Prostate Imaging Reporting and Data System version 2 (PI-RADS V2) 3 category lesions are of intermediate status with an equivocal risk of presenting clinically significant prostate cancer (csPCa). How to avoid excessive biopsies while improving the csPCa detection rate in these lesions h...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuo, Zhao, Wenlu, Tan, Shuangxiu, Zhang, Yueyue, Wei, Chaogang, Chen, Tong, Shen, Junkang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354292/
https://www.ncbi.nlm.nih.gov/pubmed/32676408
http://dx.doi.org/10.21037/tau-19-755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354292/
https://www.ncbi.nlm.nih.gov/pubmed/32676408
http://dx.doi.org/10.21037/tau-19-755

Ejemplares similares